Pfizer COVID-19 pill could cut severe illness by 89%, company says
Fox News
Pfizer Inc. announced Friday that its pill to treat novel COVID-19 was found to reduce the risk of hospitalization or death by 89% among high-risk adult patients in a clinical trial.
Similar reductions in COVID-19-related hospitalization or death were observed in patients – who were unvaccinated with mild to moderate symptoms – treated within five days of symptom onset.
Few details were reported on side effects but Pfizer said rates of problems were similar between the two groups at about 20%.
More Related News